id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2016-D-3548-0013,FDA,FDA-2016-D-3548,Public Warning and Notification of Recalls; Guidance for Industry and FDA Staff; Availability,Notice,Notice of Availability,2019-02-08T05:00:00Z,2019,2,2019-02-08T05:00:00Z,,2019-02-08T15:05:27Z,2019-01603,0,0,0900006483a55f5c
FDA-2016-D-3548-0014,FDA,FDA-2016-D-3548,"Public Warning and Notification of Recalls Under 21 CFR Part 7, Subpart C;
Guidance for Industry and FDA Staff",Other,Guidance,2019-02-08T05:00:00Z,2019,2,2019-02-08T05:00:00Z,,2024-11-12T22:54:26Z,,1,0,0900006483a567bb
FDA-2016-D-3548-0002,FDA,FDA-2016-D-3548,"Public Warning and Notification of Recalls Under 21 CFR Part 7, Subpart C
Guidance for Industry and FDA Staff",Other,Guidance,2018-01-19T05:00:00Z,2018,1,2018-01-19T05:00:00Z,2018-03-21T03:59:59Z,2024-11-07T01:20:34Z,,1,0,0900006482e2fe47
FDA-2016-D-3548-0001,FDA,FDA-2016-D-3548,"Public Warning and Notification of Recalls Under 21 CFR Part 7, Subpart
C; Draft Guidance for Industry and Food and Drug Administration Staff;
Availability",Proposed Rule,GDL Guidance,2018-01-19T05:00:00Z,2018,1,2018-01-19T05:00:00Z,2018-03-21T03:59:59Z,2018-03-21T13:03:35Z,2018-00918,0,0,0900006482e2ebf3